NICE was unable to develop medical technologies guidance on the Assurance Nasal Alar SpO2 Sensor because no evidence submission was received from the company. 27 March 2017 Discontinued. NICE was ...
NICE was unable to develop medical technologies guidance on the Assurance Nasal Alar SpO2 Sensor because no evidence submission was received from the company. 27 March 2017 Discontinued. NICE was ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する
フィードバック